Company Filing History:
Years Active: 2015-2022
Title: Andrea Leubitz: Innovator in Tumor Treatment
Introduction
Andrea Leubitz is a prominent inventor based in Efrat, Israel. She has made significant contributions to the field of medical innovations, particularly in cancer treatment. With a total of 5 patents, her work focuses on utilizing adenoviruses to combat tumors effectively.
Latest Patents
One of her latest patents involves treatment methods using adenovirus. This invention provides methods for reducing or eliminating tumors by inhibiting neo-vascularization or angiogenesis in a patient. The approach includes administering an adenovirus that comprises a nucleic acid construct with a FAS-chimera gene linked to an endothelial cell-specific promoter. Additionally, she has developed a homogeneous population of adenoviruses with similar constructs and their various uses. Another notable patent focuses on methods of inducing responsiveness to anti-angiogenic agents. This invention aims to improve the effectiveness of VEGF antagonists by administering an adenovirus alongside the antagonist.
Career Highlights
Throughout her career, Andrea has worked with notable companies such as Vascular Biogenics Ltd. and Vascular Biogenetics Ltd. Her innovative approaches have positioned her as a key figure in the development of advanced cancer therapies.
Collaborations
Andrea has collaborated with esteemed colleagues, including Erez Feige and Eyal Breitbart. These partnerships have further enhanced her research and development efforts in the medical field.
Conclusion
Andrea Leubitz is a trailblazer in the realm of tumor treatment, with her innovative patents paving the way for new therapeutic strategies. Her contributions continue to impact the medical community positively.